BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wijnsma KL, Schijvens AM, Rossen JWA, Kooistra-Smid AMDM, Schreuder MF, van de Kar NCAJ. Unusual severe case of hemolytic uremic syndrome due to Shiga toxin 2d-producing E. coli O80:H2. Pediatr Nephrol 2017;32:1263-8. [PMID: 28343354 DOI: 10.1007/s00467-017-3642-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Stevens MJA, Cernela N, Müller A, Nüesch-Inderbinen M, Stephan R. Draft Genome Sequences of 19 Clinical stx-Harboring Escherichia coli O80:H2 Strains. Microbiol Resour Announc 2021;10:e00033-21. [PMID: 33737351 DOI: 10.1128/MRA.00033-21] [Reference Citation Analysis]
2 Cointe A, Birgy A, Bridier-Nahmias A, Mariani-Kurkdjian P, Walewski V, Lévy C, Cohen R, Fach P, Delannoy S, Bidet P, Bonacorsi S. Escherichia coli O80 hybrid pathotype strains producing Shiga toxin and ESBL: molecular characterization and potential therapeutic options. J Antimicrob Chemother 2020;75:537-42. [PMID: 31773130 DOI: 10.1093/jac/dkz484] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
3 Wijnsma KL, Duineveld C, Wetzels JFM, van de Kar NCAJ. Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use. Pediatr Nephrol 2019;34:2261-77. [PMID: 30402748 DOI: 10.1007/s00467-018-4091-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
4 Long J, Xu Y, Ou L, Yang H, Xi Y, Chen S, Duan G. Utilization of Clustered Regularly Interspaced Short Palindromic Repeats to Genotype Escherichia coli Serogroup O80. Front Microbiol 2020;11:1708. [PMID: 32793166 DOI: 10.3389/fmicb.2020.01708] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Santos ACM, Santos FF, Silva RM, Gomes TAT. Diversity of Hybrid- and Hetero-Pathogenic Escherichia coli and Their Potential Implication in More Severe Diseases. Front Cell Infect Microbiol 2020;10:339. [PMID: 32766163 DOI: 10.3389/fcimb.2020.00339] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
6 Nüesch-inderbinen M, Cernela N, Wüthrich D, Egli A, Stephan R. Genetic characterization of Shiga toxin producing Escherichia coli belonging to the emerging hybrid pathotype O80:H2 isolated from humans 2010–2017 in Switzerland. International Journal of Medical Microbiology 2018;308:534-8. [DOI: 10.1016/j.ijmm.2018.05.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
7 Goh K, Li H, Lam K. Urease catalytic behaviors induced by both urea and salt concentrations in ion-exchange hydrogels as dialysis membranes. Reactive and Functional Polymers 2018;127:74-84. [DOI: 10.1016/j.reactfunctpolym.2018.03.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 De Rauw K, Thiry D, Caljon B, Saulmont M, Mainil J, Piérard D. Characteristics of Shiga toxin producing- and enteropathogenic Escherichia coli of the emerging serotype O80:H2 isolated from humans and diarrhoeic calves in Belgium. Clin Microbiol Infect 2019;25:111.e5-8. [PMID: 30076975 DOI: 10.1016/j.cmi.2018.07.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
9 Cointe A, Bizot E, Delannoy S, Fach P, Bidet P, Birgy A, Weill FX, Lefèvre S, Mariani-Kurkdjian P, Bonacorsi S. Emergence of New ST301 Shiga Toxin-Producing Escherichia coli Clones Harboring Extra-Intestinal Virulence Traits in Europe. Toxins (Basel) 2021;13:686. [PMID: 34678979 DOI: 10.3390/toxins13100686] [Reference Citation Analysis]
10 Joseph A, Cointe A, Mariani Kurkdjian P, Rafat C, Hertig A. Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review. Toxins (Basel) 2020;12:E67. [PMID: 31973203 DOI: 10.3390/toxins12020067] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 16.0] [Reference Citation Analysis]
11 Habets A, Crombé F, Nakamura K, Guérin V, De Rauw K, Piérard D, Saulmont M, Hayashi T, Mainil JG, Thiry D. Genetic characterization of Shigatoxigenic and enteropathogenic Escherichia coli O80:H2 from diarrhoeic and septicaemic calves and relatedness to human Shigatoxigenic E. coli O80:H2. J Appl Microbiol 2021;130:258-64. [PMID: 32599678 DOI: 10.1111/jam.14759] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Lang C, Hiller M, Konrad R, Fruth A, Flieger A. Whole-Genome-Based Public Health Surveillance of Less Common Shiga Toxin-Producing Escherichia coli Serovars and Untypeable Strains Identifies Four Novel O Genotypes. J Clin Microbiol 2019;57:e00768-19. [PMID: 31366691 DOI: 10.1128/JCM.00768-19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Gigliucci F, van Hoek AHAM, Chiani P, Knijn A, Minelli F, Scavia G, Franz E, Morabito S, Michelacci V. Genomic Characterization of hlyF-positive Shiga Toxin-Producing Escherichia coli, Italy and the Netherlands, 2000-2019. Emerg Infect Dis 2021;27:853-61. [PMID: 33622476 DOI: 10.3201/eid2703.203110] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Mahat U, Matar RB, Rotz SJ. Use of complement monoclonal antibody eculizumab in Shiga toxin producing Escherichia coli associated hemolytic uremic syndrome: A review of current evidence. Pediatr Blood Cancer 2019;66:e27913. [PMID: 31286658 DOI: 10.1002/pbc.27913] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
15 Cointe A, Birgy A, Mariani-Kurkdjian P, Liguori S, Courroux C, Blanco J, Delannoy S, Fach P, Loukiadis E, Bidet P, Bonacorsi S. Emerging Multidrug-Resistant Hybrid Pathotype Shiga Toxin-Producing Escherichia coli O80 and Related Strains of Clonal Complex 165, Europe. Emerg Infect Dis 2018;24:2262-9. [PMID: 30457551 DOI: 10.3201/eid2412.180272] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
16 Mauras M, Bacchetta J, Duncan A, Lavocat MP, Rohmer B, Javouhey E, Collardeau-Frachon S, Sellier-Leclerc AL. Escherichia coli-associated hemolytic uremic syndrome and severe chronic hepatocellular cholestasis: complication or side effect of eculizumab? Pediatr Nephrol 2019;34:1289-93. [PMID: 30963282 DOI: 10.1007/s00467-019-04234-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]